Hoyle, AP;
Ali, A;
James, ND;
Cook, A;
Parker, CC;
de Bono, JS;
Attard, G;
... STAMPEDE Investigators; + view all
(2019)
Abiraterone in "High-" and "Low-risk" Metastatic Hormone-sensitive Prostate Cancer.
European Urology
, 76
(6)
pp. 719-728.
10.1016/j.eururo.2019.08.006.